These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 34979867)

  • 1. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
    Sun MY; Wang L; Shen ZY
    Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1.
    Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
    Aging (Albany NY); 2021 Sep; 13(17):21325-21344. PubMed ID: 34499615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
    Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
    Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration.
    Song M; Wang Y; Zhang Z; Wang S
    Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMC2/CCND1 axis promotes development of ovarian cancer through regulating cell growth, apoptosis and migration.
    Zhu D; Huang J; Liu N; Li W; Yan L
    Cell Death Dis; 2021 Jul; 12(8):730. PubMed ID: 34294689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Proteasome 26S Subunit ATPase 2 Regulates Colorectal Cancer Cell Proliferation, Apoptosis, and Migration.
    He J; Xing J; Yang X; Zhang C; Zhang Y; Wang H; Xu X; Wang H; Cao Y; Xu H; Zhang C; Wang C; Yu E
    Chemotherapy; 2019; 64(3):146-154. PubMed ID: 31715603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSMC2 knockdown exerts an anti-tumor role in nasopharyngeal carcinoma through regulating AKT signaling pathway.
    Su J; Hu S; Ding S; Feng K
    Cell Cycle; 2023 Nov; 22(21-22):2381-2391. PubMed ID: 38123344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
    Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
    Qu Y; He Y; Ruan H; Qin L; Han Z
    Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression.
    Zhang G; Wang H; Liu G; Huang J
    Pathol Res Pract; 2024 Jan; 253():155021. PubMed ID: 38103366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
    Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU).
    Wang Y; Zhu M; Li J; Xiong Y; Wang J; Jing H; Gu Y
    Cell Death Dis; 2021 Jul; 12(7):690. PubMed ID: 34244472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K/AKT pathway in OLP-associated OSCC.
    Liu Y; Cao P; Xiao L; Tang N; Fei W; Li X
    J Cell Mol Med; 2024 Jul; 28(14):e18556. PubMed ID: 39039706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
    Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
    Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
    Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
    Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
    Shan F; Shen S; Wang X; Chen G
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway.
    Wang Y; Zhang S; Zhao Z; Jin Q; Wang Z; Song Z; Liu L; Zhao Z
    Immunobiology; 2024 May; 229(3):152802. PubMed ID: 38569452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
    Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
    Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.